MedTrace Logo

Postmarketing Multicenter Study of Intra-Articular DIART ONE / EASYGO ONE for Knee Osteoarthritis

NCT06927934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2025-04-15

No results posted yet for this study

Summary

This study looked at how safe and effective a hyaluronic acid-based injection (called DIART ONE or EASYGO ONE) is for people with knee osteoarthritis. The injection helps replace the natural fluid in the knee joint to reduce pain and improve movement. Patients received one injection, and their symptoms were tracked over 6 months using phone calls and clinic visits. The goal was to see how much pain and joint function improved, and to check for any side effects.

Conditions

Sponsors & Collaborators

  • Pharmaxi Clinical Research LLC

    collaborator UNKNOWN

  • Yuria-Pharm

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-14
Primary Completion
2022-06-06
Completion
2022-06-27

Countries

  • Ukraine

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06927934 on ClinicalTrials.gov